Cigna has deleveraged substantially after acquiring Express Scripts in late 2018 when Cigna's debt rose to over $42 billion, or debt/capital of 51%. Management has made good progress on its ...

The 3 largest pharmacy benefit managers (PBMs) increased many specialty generic drugs prices by hundreds of percent, with ...

Insurer-pharmacy benefit manager (PBM) firms control most of the Medicare Part D market, steering patients to their ...

The Federal Trade Commission published a second interim staff report this week on the prescription drug middleman industry, which ...

Broader health insurance and PBM sector stocks including Centene, CVS, Elevance Health and Humana decline as investors react to market. Get Wall Street's Hottest Chart Every Morning What To Know ...

LITTLE ROCK, Ark. — High drug costs and struggling local pharmacies have become critical challenges for Arkansans. That reality is the very reason that's prompting lawmakers to take action ...

A transformation in the PBM space will likely lead to fairer pricing ... This aggressive transition could mean tremendous profits for nuclear-related stocks – and investors who get in on the ...

These companies are considered the “Big 3” in the PBM industry, controlling roughly ... As is noted in the report, there is no set definition for what specialty drugs are.

The FTC released a 60-page report Tuesday targeting the biggest three pharmacy benefit managers, claiming the companies hiked ...

A handful of marquee companies have taken this plunge, meaning it’s no longer a matter ... The traditional PBM model is doomed to be a shell of itself within the next five years.

At that point, the reserves will be tapped, and the program can only pay out what it brings in, which, according to the Congressional Budget Office (CBO), could mean a 23% across-the-board cut to ...